F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for...
F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors
About this item
Full title
Author / Creator
Publisher
Egypt
Journal title
Language
English
Formats
Publication information
Publisher
Egypt
More information
Scope and Contents
Contents
Aim. (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) is a powerful tool for staging and defining "good responders" to chemotherapy in tumor setting. Gastrointestinal stromal tumors (GISTs) are sarcoma involving gastrointestinal tract and may require a chemotherapy including imatinib, a tyrosine kinase inhibitor agent. Some GIS...
Alternative Titles
Full title
F-FDG PET Imaging in the Evaluation of Treatment Response to New Chemotherapies beyond Imatinib for Patients with Gastrointestinal Stromal Tumors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_898203177
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_898203177
Other Identifiers
E-ISSN
2090-4401
DOI
10.5402/2011/824892
